Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2004-12-20
2008-10-28
Weddington, Kevin E (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S003100, C514S635000, C514S866000
Reexamination Certificate
active
07442720
ABSTRACT:
The subject invention provides compositions and methods for treating diabetes in patients. In a preferred embodiment, the invention provides compositions methods for treating diabetes and/or preventing or alleviating complications associated with diabetes. Specifically exemplified herein is the concurrent administration of a cysteamine compound with at least one additional therapeutic agent to prevent and/or treat diabetes as well as prevent and/or treat complications associated with diabetes. In a preferred embodiment, oral administration of cysteamine hydrochloride with Metformin to a patient diagnosed with diabetes can substantially regulate the patient's glucose metabolism and insulin sensitivity.
REFERENCES:
patent: 5284874 (1994-02-01), Clark et al.
patent: 5401880 (1995-03-01), Clark et al.
patent: 5668117 (1997-09-01), Shapiro
patent: 5714519 (1998-02-01), Cincotta et al.
patent: 6521266 (2003-02-01), Mann
patent: 6630176 (2003-10-01), Li et al.
patent: 6746678 (2004-06-01), Shapiro
patent: 2004/0033985 (2004-02-01), Chi et al.
patent: 2004/0106591 (2004-06-01), Pacioretty et al.
patent: 2005/0143473 (2005-06-01), Wong et al.
patent: 2005/0148674 (2005-07-01), Tang et al.
patent: 2002187839 (2002-07-01), None
patent: WO 95/01096 (1995-01-01), None
patent: WO 01/95944 (2001-12-01), None
Http://www.Drugs.com/metformin.html (2007).
Http://www.people.vcu.edu/urdesai/bigu.htm (2007).
Http://en.wikipedia.org/wiki/Buformin (2007).
Kano, M. et al., “Soymilk Products Affect Ethanol Absorption and Metabolism in Rats During Acute and Chronic Ethanol Intake,”American Society for Nutritional Sciences, 2002, pp. 238-244.
Vescei et al., “Preclinical and Clinical Studies With Cysteamine and Pantethine Related to the Central Nervous System,”Prg. Neuro-psychopharmacol., 1990, 14:835-862.
Wall, T. L. et al., “Alcohol Metabolism in Asian American Men With Genetic Polymorphisms of Aldehyde Dehydrogenase,”Annals of Int. Med., 1997, 127(5):376-379.
Windholz et al., The Merck Index, Tenth Edition, 1983, pp. 849-850, abstract No. 5792.
U.S. Appl. No. 11/118,737, filed Apr. 29, 2005.
Gennes, J.L. et al., “Effets De Cystamine Dans Differentes Affections Allergiques,”Semaine Des Hopitaux De Paris, Expansion Scientifique Francaise(1956), 32(56): 2850-2853.
Gyenes, L. et al., “The Properties of Fragments of Skin-Sensitizing and Blocking Antibodies as Revealed by the Prausnitz-Kuestner, Passive Cutaneous Anaphylaxis and Hemagglutination Reactions,”International Archives of Allergy and Applied Immunology(1964), 24: 106-118.
Landers, M. C. et al., “Permanent-Wave Dermatitis: Contact Allergy to Cysteamine Hydrochloride,”American Journal of Contact Dermatitis(2003), 14(3): 157-160.
Chan Bill Piu
Chi Francis
Po Wong Gary Kwan
Xu Jinxian
Omega Bio-Pharma (I.P.3) Limited
Saliwanchik Lloyd & Saliwanchik
Weddington Kevin E
LandOfFree
Compositions and methods for treating diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4001654